Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
In addition, the A alleles in CHRNA3 rs1051730 and CHRNA5 rs16969968 were associated with the risk for LC (OR = 1.66, P = 0.07 and OR = 1.57, P = 0.1, respectively) and for COPD (OR = 2.04, P = 0.01 and OR = 1.91, P = 0.02, respectively).
|
29993116 |
2018 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
SNP rs16969968 as a Strong Predictor of Nicotine Dependence and Lung Cancer Risk in a North Indian Population
|
29172281 |
2017 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Studies link a gene cluster encoding for α3β4α5-D398N nicotinic acetylcholine receptors to lung cancer risk as well as link a second mutation in this cluster to an increased risk for nicotine dependence.
|
28045487 |
2017 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
The potential association of three polymorphisms in the CHRNA3 (rs1051730(G > A)), CHRNA5 (rs16969968(G > A)), and AGPHD1 (rs8034191(A > G)) with the lung cancer risk has been widely investigated, but the results are inconsistent.
|
27072204 |
2016 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
These results: 1) underscore the potential value of smoking cessation for all smokers, 2) suggest that CHRNA5 rs16969968 genotype affects lung cancer diagnosis through its effects on smoking, and 3) have potential value for framing preventive interventions for those who smoke.
|
27543155 |
2016 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Given the existing evidence that this CHRNA5 variant predicts favorable response to cessation pharmacotherapy, these findings underscore the potential clinical and public health importance of rs16969968 in CHRNA5 in relation to smoking cessation success and lung cancer risk.
|
25873736 |
2015 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our meta-analysis provided statistical evidence for a strong association between rs16969968 polymorphism and the risk of lung cancer, especially in smokers and Caucasians.
|
26434895 |
2015 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Accordingly, rs588765-rs16969968 may be a genetic marker to lung cancer risk, even among never-smokers.
|
26282330 |
2015 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Further, these results suggest that the association between rs16969968 and lung cancer may be mediated by the quantity of smoke inhaled.
|
23358500 |
2014 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
No association with lung cancer risk was found for CHRNA5 rs16969968.
|
23178447 |
2013 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our results also confirm and extend previous findings for associations between rs16969968 and lung cancer, loss of lung function equivalent to that of COPD, and smoking quantity.
|
23443019 |
2013 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
The increase in cotinine levels indicated an increased risk of lung cancer with each additional copy of the rs1051730-rs16969968 risk allele (per-allele odds ratio = 1.31, 95% CI = 1.21 to 1.42).
|
22534784 |
2012 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
The A allele of the SNP rs16969968 (alpha5, G>A), which correlates with the development of lung cancer, shows a non-significant trend to be associated with cervical lesions.
|
22406075 |
2012 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
A rare variant of chromosomal region 15q25.1, marked by rs16969968 (substitution 1354G>A in CHRNA5), was found to be associated with increased lung cancer and nicotine-dependence risk.
|
21955800 |
2012 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Additional SNP associations were observed on 15q25.1 in genes previously associated with lung cancer, including a missense variant in CHRNA5 (rs16969968: OR = 1.60, 95% CI = 1.27-2.01, P = 5.9 x 10-5).
|
23232035 |
2012 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Diplotype analysis of rs3841324 with either rs16969968 or rs8034191 showed that these polymorphisms influenced the lung cancer risk independently.
|
22028403 |
2011 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Two variants in the nicotinic acetylcholine receptor subunit genes CHRNA5 and CHRNA3 on 15q25, rs16969968 and rs578776, were associated with cotinine (P = 0.001 and 0.03, respectively) in current smokers and with lung cancer risk (P < 0.001 and P = 0.001, respectively).
|
21862624 |
2011 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
However, rs7452888 (6q27) was identified as a possible candidate SNP to influence lung cancer survival, while stratified analysis hinted at a possible role for rs8034191, rs16969968 (15q25.1) and rs4324798 (6p22.1) in influencing survival time in lun</span>g cancer patients who were never-smokers, based on a small sample.
|
21750227 |
2011 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
The rs16969968-lung cancer association did not differ by intake level of most dietary factors examined, but was stronger for individuals diagnosed at < 70 years of age or having a baseline smoking history of <40 cigarette pack-years.
|
21229299 |
2011 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Recently, to identify genetic factors that modify lung cancer risk, CHRNA5 non-synonymous variant amino acid position 398 (D398N) was identified.
|
19577767 |
2010 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
Associations between 15q25 and the risk of lung cancer were replicated in white ever-smokers (rs16969968: odds ratio [OR] = 1.26, 95% confidence interval [CI] = 1.21 to 1.32, P(trend) = 2 x 10(-26)), and this association was stronger for those diagnosed at younger ages.
|
20548021 |
2010 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
A four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002).
|
20587604 |
2010 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
In models adjusting for cigarettes-per-day, we confirm the association between rs16969968 and lung cancer (p<10(-20)) and observe a nominally significant association with COPD (p = 0.01); the other loci are not significantly associated with either lung cancer or COPD after adjusting for rs16969968.
|
20700436 |
2010 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
We performed a detailed analysis of one 15q single nucleotide polymorphism (SNP) (rs16969968) with smoking behaviour and cancer risk in a total of 17 300 subjects from five LC studies and four upper aerodigestive tract (UADT) cancer studies.
|
19776245 |
2010 |
Malignant neoplasm of lung
|
|
0.100 |
GeneticVariation
|
BEFREE |
We conclude that there are at least two distinct mechanisms conferring risk for nicotine dependence and lung cancer: altered receptor function caused by a D398N amino acid variant in CHRNA5 (rs16969968) and variability in CHRNA5 mRNA expression.
|
19443489 |
2009 |